课题基金 / 基金详情

HUMAN CELL SURFACE ANTIGENS: TRANSFERRIN RECEPTORS

HUMAN CELL SURFACE ANTIGENS: TRANSFERRIN RECEPTORS
人类细胞表面抗原:转铁蛋白受体
批准号:
3172606
负责人:
IAN S TROWBRIDGE
金额:
$11.64万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-06-01 至 1986-05-31

项目摘要

项目成果

IAN S TROWBRIDGE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Monoclonal antibodies have been used in earlier studies in this laboratory to identify and characterize the transferrin receptors of human and murine cells. Transferrin receptors are associated with active cell growth and are selectively expressed on some tumors in vivo. Monoclonal antibodies have been obtained that block receptor function and inhibit tumor cell growth in vitro. This work is being developed in two directions. The human transferrin receptor gene has been isolated and can be expressed in the appropriate cell type. Efforts are underway to use oligonucleotide site-directed mutagenesis E to study the structure-function relationship of the human transferrin receptor. The other aspect of the project is to investigate the effects of monoclonal antibodies that block transferrin receptor function on the growth of tumor cells in vivo. In the past year, it has been shown that a rat IgM monoclonal antibody against the murine transferrin receptor can inhibit the growth of a syngeneic leukemia, SL-2, in AKR/J mice. Both inhibition of growth of the primary subcutaneous tumor and prolonged survival of tumor-bearing mice were demonstrated. There was no evidence of toxicity associated with administration of the antibody. The distribution of transferrin receptors on murine hematopoietic stem cells has also been investigated. (CS)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTITUMOR THERAPY WIH ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODIES
  • 批准号:
    6102191
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1997
  • 负责人:
    IAN S TROWBRIDGE
  • 依托单位:
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
海外基金